PPT-Aspirin for Preventing the Recurrence of Venous
Author : liane-varnes | Published Date : 2017-03-20
Thromboembolism N Engl J Med 2012366195967 VTE Prevalence Incidence of DVT 48 per 100000 Incidence of PE 23 per 100000 Casefatality rate Inpatient 12 1year 19
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Aspirin for Preventing the Recurrence of..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Aspirin for Preventing the Recurrence of Venous: Transcript
Thromboembolism N Engl J Med 2012366195967 VTE Prevalence Incidence of DVT 48 per 100000 Incidence of PE 23 per 100000 Casefatality rate Inpatient 12 1year 19 3year 30. Aspirin. Used as an analgesic (pain killer) for headaches, toothaches, neuralgia (nerve pain), muscle pain and joint pain.. Also effective as a fever reducer and anti-inflammatory.. Has anticoagulant properties – prevents strokes and heart attacks.. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . . البورد العربي . كلية طب الموصل . . . . 2011. . . Chapter 14. Aspirin. Pharmaceutical products are often developed from substance found in a plant that has been used for traditional medicine.. Aspirin is one of these products.. Salicylic acid is the active substance that helps . how old to buy motrin. what is motrin 400 mg used for. can i buy motrin 800 over the counter. is acetaminophen tylenol or motrin. gave child tylenol motrin same time. mcneil tylenol motrin dosing chart. (EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS. PGY2 Cardiology Resident. WakeMed. Health & . Hosptials. Raleigh, NC. Dr. . Ryan Sparks (presenter). Current PGY2 Cardiology Resident at . WakeMed. The sensation of pain – our ability to perceive pain is one of our best defense mechanisms. . Pain allows us to act in a way that reduces further damage to our bodies. For example, removing the hand from a hot plate or not being able to continue running after pulling a muscle.. No aspirin (n = 7,335) JPPP Primary endpoint (CV death/MI/stroke) for aspirin vs. no aspirin: 2.8% vs. 3.0%, p = 0.54 CV death: 0.86 % vs. 0.78%, p = 0.89 ; nonfatal cerebrovascular disease: 1.65 Original Article Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism Timothy A. Brighton, M.B., B.S., John W. Eikelboom, M.B., B.S., Kristy Mann, M.Biostat., Rebecca Mister, M.Sc., Alexander Gallus, M.B., B.S., Paul Ockelford, M.B., Harry Gibbs, M.B., Wendy Hague, Ph.D., Denis Xavier, M.Sc., Rafael Diaz, M.D., Adrienne Kirby, M.Sc., John Simes, M.D., for the ASPIRE Investigators Therapeutic uses & contraindication. Aspirin . act as an analgesic, antipyretic, Anti-inflammatory also inhibit platelet aggregation & prolongs bleeding time, because of its effect on G.I.T it is contraindicated in peptic . SOMA Soma ( Soma Compound w/Codeine (carisoprodol and aspirin and codeine) Soma FEP Clinical Rationale RATIONALE FOR INCLUSION IN PA PROGRAM Background Soma , Soma Compound, and Soma Compound with Kathleen M. Buchheit, MD. Assistant Director, AERD Center. Allergy & Immunology. Brigham and Women’s Hospital. September 13, 2019. Conflict of Interest Disclosure . Relevant financial relationships with commercial interests in the preceding 12 months: Regeneron, Genentech. Primary endpoint . (CV death/MI/stroke) for aspirin vs. no aspirin: . 2.8% vs. 3.0%, . p = 0.54 . CV . death: 0.86. % vs. 0.78%, . p = 0.89. ; nonfatal . cerebrovascular . disease: 1.65. % vs. 1.64%, . 89 non-cardioembolic stroke detected by rapid platelet function analyzer Jose C NAVARRO MD MSc , Annabelle Y LAO MD , Maricar P YUMUL MD , Maria Leticia C ARAULLO MD , Johnny K LOKIN MD , Aleja (n . = 6,589). SOCRATES. Primary outcome, death, MI or stroke, for ticagrelor vs. aspirin: . 6.7% . vs. 7.5%, HR = 0.89, 95% CI . 0.78-1.01. , . p = 0.07. Death: 1.0% vs. 0.9%, . p = 0.36; All . strokes: 5.9% vs. 6.8%, .
Download Document
Here is the link to download the presentation.
"Aspirin for Preventing the Recurrence of Venous"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents